Last update 12 Nov 2024

11C-EMO

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
11C-LSN3172176, LSN3172176, [11C]LSN3172176
Target
M1 receptor
Mechanism
M1 receptor agonists(Muscarinic acetylcholine receptor M1 agonists), PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
Other Diseases
Active Indication
Diagnostic agents
Inactive Indication
Schizoaffective disorderSchizophrenia
Originator Organization
Eli Lilly & Co. Ltd.
Active Organization
Eli Lilly & Co. Ltd.Janssen Scientific Affairs LLC
Inactive Organization
Yale UniversityYale UniversityNational Institute of Mental HealthNational Institute of Mental Health
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with 11C-EMO
NCT06014385 / Not yet recruitingPhase 1IIT
A Trial to Evaluate Target Occupancy of Scopolamine at the Muscarinic M1 Receptor
NCT05105542 / CompletedPhase 2IIT
Muscarinic M1 Receptor Availability and Cognition in Schizophrenia
100 Clinical Results associated with 11C-EMO
Login to view more data
100 Translational Medicine associated with 11C-EMO
Login to view more data
100 Patents (Medical) associated with 11C-EMO
Login to view more data
100 Deals associated with 11C-EMO
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Schizoaffective disorderPhase 2
US
National Institute of Mental HealthNational Institute of Mental Health
20 Apr 2021
SchizophreniaPhase 2
US
National Institute of Mental HealthNational Institute of Mental Health
20 Apr 2021
Diagnostic agentsPreclinical
US
Eli Lilly & Co. Ltd.
11 Apr 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
SNMMI2017
Not Applicable
-
-
(11C-LSN3172176)
mdpkyiipnu(gogxwirzod) = cdaxqavnew glqixycldi (qkexundxly, 3)
View more
-
24 May 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free